Results 51 to 60 of about 961 (180)

Primary cilia–extracellular vesicle crosstalk in Alzheimer's disease: Emerging mechanisms and biomarker potential

Alzheimer's &Dementia, Volume 22, Issue 7, July 2026.
Abstract Alzheimer's disease (AD) is a neurodegenerative condition marked by cognitive decline and synaptic issues. Recent studies show primary cilia (PCs), sensory organelles present on the surface of most mammalian cells, act as a critical regulators of brain homeostasis and signaling.
Vishal Singh Guleria, Charisse N. Winston   +1 more
wiley   +1 more source

Non–fungible tokens in the structure of Islamic financingl markets

Путеводитель предпринимателя, 2023
The widespread use of innovative technologies in the Arab countries began relatively recently; the COVID–19 pandemic became a powerful impetus to their promotion.
S. Yu. Babenkova
doaj   +1 more source

Proteomics of post mortem brains in early‐ and late‐onset Alzheimer's disease: Unraveling differential Aβ effects and potential AD biomarkers

Alzheimer's &Dementia, Volume 22, Issue 7, July 2026.
Abstract BACKGROUND Alzheimer's disease (AD) occurs primarily as late‑onset (LOAD) and less frequently as early‑onset (EOAD). Its defining pathologies are hyperphosphorylated tau tangles and amyloid beta (Aβ) plaques. METHODS We analyzed the proteomes of 115 post mortem temporal lobe samples by mass spectrometry and searched with a dedicated AD ...
Evangelia Thanou, Andrea Ganz, Débora Pita‐Illobre, Frank Koopmans, Jeroen J. M. Hoozemans, Annemieke Rozemuller, Henne Holstege, August B. Smit, Ka Wan Li   +8 more
wiley   +1 more source

Rethinking Alzheimer's Disease Therapy: From Amyloid‐Centric Approaches to Multi‐Target Phytochemical Strategies

Journal of Neurochemistry, Volume 170, Issue 7, July 2026.
Alzheimer's disease is driven by interconnected pathological processes, including amyloid‐β aggregation, tau hyperphosphorylation, neuroinflammation, oxidative stress, synaptic dysfunction, and mitochondrial impairment. While recently approved anti‐amyloid therapies represent an important advance, their modest clinical benefits highlight the ...
Emre Aktaş, İlay Yurt, Yağmur Nisa Cerlet, Haşmet Ayhan Hanağası   +3 more
wiley   +1 more source

What Is the Right Price for Non-Fungible Tokens (NFTs)? A Systematic Review of the Current Literature

FinTech
Non-Fungible Tokens (NFTs) have transformed digital ownership, offering unique representations of assets such as art, collectibles, and virtual property. However, pricing NFTs remains a complex and underexplored issue.
Marta Flamini, Maurizio Naldi
doaj   +1 more source

Contributions of the Alzheimer's Disease Neuroimaging Initiative to advancing AD research: a targeted review of recent publications

Alzheimer's &Dementia, Volume 22, Issue 6, June 2026.
Abstract The Alzheimer's Disease Neuroimaging Initiative (ADNI) recently celebrated its 20th anniversary, reflecting two decades of major contributions to Alzheimer's research through open data sharing and longitudinal multimodal assessments. This review synthesizes 122 high‐impact studies using ADNI data or biospecimens from 2023 to mid‐2025 to ...
Dallas P. Veitch, Melanie J. Miller, Shaveta Kanoria, Paul S. Aisen, Laurel A. Beckett, Robert C. Green, Danielle J. Harvey, Clifford R. Jack Jr., William Jagust, Edward B. Lee, Kwangsik Nho, Rachel Nosheny, Ozioma C. Okonkwo, Richard J. Perrin, Ronald C. Petersen, Monica Rivera Mindt, Andrew J. Saykin, Leslie M. Shaw, Arthur W. Toga, Duygu Tosun, Susan M Landau, Michael W. Weiner, for the Alzheimer's Disease Neuroimaging Initiative   +22 more
wiley   +1 more source

Vulnerability of the locus coeruleus–entorhinal cortex white matter tract in autosomal dominant Alzheimer's disease

Alzheimer's &Dementia, Volume 22, Issue 6, June 2026.
Abstract INTRODUCTION Locus coeruleus (LC) structural integrity declines early in sporadic and autosomal dominant Alzheimer's disease (AD). We examined LC–entorhinal cortex (LC‐EC) tract integrity and its association with amyloid and tau pathology and memory in autosomal dominant AD (ADAD).
Elouise A. Koops, Averi Giudicessi, Ana Baena, Lusiana Martinez, Nikole Bonillas‐Felix, Randy Medrano, Joyita Dutta, Isabela Gonzalez, Sergio Alvarez, David Aguillon, Yakeel T. Quiroz, Heidi I. L. Jacobs   +11 more
wiley   +1 more source

NON-FUNGIBLE TOKENS AND ART TOKENIZATION: A TOOL FOR MONEY LAUNDERING?

Zeszyty Prawnicze
This article examines the NFT market and art tokenization in the context of money laundering. It explores the evolution of the art market toward digitalization, the definition of NFTs, and their legal and technical aspects.
Krystian Bartnik
doaj   +1 more source

Hippocampal GFAP in aging: Associations with AD and LATE‐NC pathologies and cognitive decline in older adults

Alzheimer's &Dementia, Volume 22, Issue 6, June 2026.
Abstract INTRODUCTION Plasma glial fibrillary acidic protein (GFAP) is an emerging biomarker for Alzheimer's disease (AD) progression in clinical studies, yet the role of brain GFAP in AD/AD‐related dementias (ADRD) pathologies and cognitive decline remains unclear. METHODS GFAP burden from CA1‐subiculum of the hippocampus were quantified.
Sonal Agrawal, Lei Yu, Sue E. Leurgans, Jialiang Li, Alifiya Kapasi, Puja Agarwal, Jeffrey L. Dage, Lisa L. Barnes, David A. Bennett, Patricia Boyle, Julie A. Schneider   +10 more
wiley   +1 more source

The fundamental value of art NFTs

, 2023
This paper examines the level of speculation associated with art non-fungible tokens (NFTs), comprehends the characteristics that confer value on them and designs a profitable trading strategy based on our findings. We analyze 860,067 art NFTs that have been deployed on the Ethereum blockchain and have been involved in 317,950 sales using machine ...
Fridgen, Gilbert, Kräussl, Roman, Papageorgiou, Orestis, Tugnetti, Alessandro   +3 more
openaire   +2 more sources